It's hard to sustain a bond market rally with stocks doing as well as they're doing.

Stocks are doing better; that has taken a little bit of froth out of the (bond) market.

We anticipate a relief rally for pharmaceutical stocks.

You really have a two-tier market with tech stocks going down and everything else going up. Part of this is because valuations in technology stocks got overdone this year and, at the same time, the Dow hadn't performed and now they look cheap.

It's hard to kill that father-son bond.

When (the TSX) opens after being closed while the U.S. market was open, all the inter-listed stocks get adjusted.